From October 1, 2012 to December 31, 2012, the company has repurchased 868,844 shares, representing 0.55% for $50 million. With this, the company has completed the repurchase of 20,727,215 shares, representing 12.39% for $1,135 million under the buyback announced on October 20, 2010.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,511 GBX | +0.03% | -1.21% | +4.19% |
07-05 | GSK: FIRST SINGLE-DOSE MEDICINE TO PREVENT RELAPSE OF P. VIVAX M… | RE |
07-05 | GSK launches antimalarial drug in Thailand and Brazil | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.19% | 78.92B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.